Corrigendum: Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease : Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study (Ophthalmology (2024) 131(11) (1324–1332), (S0161642024003191), (10.1016/j.ophtha.2024.05.024))
Source: Ophthalmology
Intraoperative Indocyanine Green to Localize a Microscopic Focus of Paraganglioma
Source: Pediatric Blood and Cancer
Pheochromocytoma in von Hippel-Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma
Source: Clinical Endocrinology
Long-term surgical outcomes and prognosis of cervical spinal hemangioblastomas
Source: Clinical Neurology and Neurosurgery
Retinal capillary hemangioma in a pthisical globe: Late sequelae in a case of Von Hippel-Lindau (VHL) disease presenting with endophthalmitis
Source: International Journal of Surgery Case Reports
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
